Saved in:
| Main Authors: | Zhi Wen, Shuai Shao, Yu Feng, Zheng Wang, Jianqiang Wu, Changxue Wu, Mingwu Tian |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Cardiac Allograft Vasculopathy in Heart Transplantation From Circulatory Death Donors: A Systematic Review and Meta‐Analysis
by: Wasif Safdar, et al.
Published: (2026)
by: Wasif Safdar, et al.
Published: (2026)
Lack of Association Between Donor‐Derived Cell‐Free DNA and Cardiac Allograft Vasculopathy
by: Rami Alharethi, et al.
Published: (2024)
by: Rami Alharethi, et al.
Published: (2024)
Association Between Right Ventricular Dysfunction and Cardiac Allograft Vasculopathy in Pediatric Patients Following Heart Transplantation
by: Teruhiko Imamura
Published: (2026)
by: Teruhiko Imamura
Published: (2026)
Right Ventricular Dysfunction by Echocardiography Is an Early Marker of Evolving Cardiac Allograft Vasculopathy in Children After Heart Transplantation
by: Judith Namuyonga, et al.
Published: (2025)
by: Judith Namuyonga, et al.
Published: (2025)
Risk Index Predicts Pediatric Heart Allograft Non‐Utilization
by: Jake Lynn, et al.
Published: (2024)
by: Jake Lynn, et al.
Published: (2024)
Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes
by: Masaki Tsuji, et al.
Published: (2025)
by: Masaki Tsuji, et al.
Published: (2025)
Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?
by: Jacqueline I. Kim, et al.
Published: (2026)
by: Jacqueline I. Kim, et al.
Published: (2026)
Association of Donor Vascular Endothelial Growth Factor Gene Polymorphism With Acute Renal Allograft Rejection
by: Narayan Prasad, et al.
Published: (2024)
by: Narayan Prasad, et al.
Published: (2024)
Long‐Term Chronic Lung Allograft Dysfunction‐Free Survival Following Lung Transplant in the Presence of Donor‐Specific Antibodies
by: Benjamin Grobman, et al.
Published: (2025)
by: Benjamin Grobman, et al.
Published: (2025)
Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
by: Ana Khazan, et al.
Published: (2026)
by: Ana Khazan, et al.
Published: (2026)
Evolving Long‐Term Outcomes of Heart Transplantation Using COVID‐19 Positive Donors
by: Ye In Christopher Kwon, et al.
Published: (2026)
by: Ye In Christopher Kwon, et al.
Published: (2026)
Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
by: Margarita A. Peradejordi Lastras
Published: (2016)
by: Margarita A. Peradejordi Lastras
Published: (2016)
Associated Clinical and Laboratory Markers of Donor on Allograft Function After Heart Transplant
by: Renato Braulio
Published: (2016)
by: Renato Braulio
Published: (2016)
Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation
by: Armaan F. Akbar, et al.
Published: (2024)
by: Armaan F. Akbar, et al.
Published: (2024)
Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
by: Eishan Ashwat, et al.
Published: (2025)
by: Eishan Ashwat, et al.
Published: (2025)
Extracorporeal Photopheresis in the Treatment of Cardiac Allograft Rejection in the Modern Era: A Single‐Center Experience
by: Gal Rubinstein, et al.
Published: (2025)
by: Gal Rubinstein, et al.
Published: (2025)
Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction
by: Johanna P. van Gemert, et al.
Published: (2025)
by: Johanna P. van Gemert, et al.
Published: (2025)
Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
by: Meagan O. Rogers, et al.
Published: (2024)
by: Meagan O. Rogers, et al.
Published: (2024)
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)
by: Vaisak O. Nair, et al.
Published: (2025)
Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
by: Ye In Christopher Kwon, et al.
Published: (2026)
by: Ye In Christopher Kwon, et al.
Published: (2026)
Donor Characteristics and Outcomes of Pediatric Heart Transplantation in South Korea
by: Susan Taejung Kim, et al.
Published: (2024)
by: Susan Taejung Kim, et al.
Published: (2024)
Intraoperative Hemodynamic Monitoring and Prediction of Early Allograft Dysfunction Following Living Donor Liver Transplantation: A Systematic Review
by: Audrey E. Brown, et al.
Published: (2025)
by: Audrey E. Brown, et al.
Published: (2025)
Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
by: Ananya Gorrai, et al.
Published: (2026)
by: Ananya Gorrai, et al.
Published: (2026)
Project Donor: A National Intervention to Improve the Health of Potential Living Donors
by: Ali B. Abbasi, et al.
Published: (2025)
by: Ali B. Abbasi, et al.
Published: (2025)
Reduced Surgical Complications After Deceased‐Donor Kidney Transplantation Using Inverted Allograft and Ultrashort Ureteroureterostomy: A Single‐Center Experience
by: Rafael Azevedo Foinquinos, et al.
Published: (2025)
by: Rafael Azevedo Foinquinos, et al.
Published: (2025)
Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes
by: Ahad Firoz, et al.
Published: (2024)
by: Ahad Firoz, et al.
Published: (2024)
Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation
by: Javier M. Zamora‐Olaya, et al.
Published: (2024)
by: Javier M. Zamora‐Olaya, et al.
Published: (2024)
Possible Donor‐Derived Tuberculosis in an Orthotopic Heart Transplant Recipient
by: Phani V. Akella, et al.
Published: (2026)
by: Phani V. Akella, et al.
Published: (2026)
Potential Role of SGLT‐2 Inhibitors in Improving Allograft Function and Reducing Rejection in Kidney Transplantation
by: Mehmet Emin Demir, et al.
Published: (2025)
by: Mehmet Emin Demir, et al.
Published: (2025)
Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors
by: Christine E. Koval, et al.
Published: (2026)
by: Christine E. Koval, et al.
Published: (2026)
Diagnostic and Prognostic Value of Myocardial Extracellular Volume Fraction Assessed Using Cardiovascular Magnetic Resonance in Patients With Restrictive Cardiac Allograft Physiology
by: Masaki Tsuji, et al.
Published: (2025)
by: Masaki Tsuji, et al.
Published: (2025)
Organ Donor Potential After Extracorporeal Cardiopulmonary Resuscitation for Out‐of‐Hospital Cardiac Arrest: A Post‐Hoc Analysis of a Randomized Controlled Trial
by: Hanne C. R. Verberght, et al.
Published: (2025)
by: Hanne C. R. Verberght, et al.
Published: (2025)
Delayed‐Onset Renal Allograft Compartment Syndrome in a Pediatric Kidney Transplant Recipient: The Role of Surgical Re‐Evaluation
by: Buğra Otludil, et al.
Published: (2025)
by: Buğra Otludil, et al.
Published: (2025)
Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era
by: Lana Hasan, et al.
Published: (2025)
by: Lana Hasan, et al.
Published: (2025)
Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
by: Iris Feng, et al.
Published: (2025)
by: Iris Feng, et al.
Published: (2025)
Skin Elasticity: A Potential Surrogate Marker for Facial Allograft Skin Fibrosis—A Case Series
by: Viola A. Stögner, et al.
Published: (2025)
by: Viola A. Stögner, et al.
Published: (2025)
Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
by: Majd Alsoubani, et al.
Published: (2025)
by: Majd Alsoubani, et al.
Published: (2025)
Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States
by: Shivank Madan, et al.
Published: (2024)
by: Shivank Madan, et al.
Published: (2024)
Hepatitis B Virus NAT Positive Donors in Non‐Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor‐Derived Infection
by: Patrick C. K. Tam, et al.
Published: (2025)
by: Patrick C. K. Tam, et al.
Published: (2025)
Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
by: Cathrine M. Moeller, et al.
Published: (2024)
by: Cathrine M. Moeller, et al.
Published: (2024)
Similar Items
-
Cardiac Allograft Vasculopathy in Heart Transplantation From Circulatory Death Donors: A Systematic Review and Meta‐Analysis
by: Wasif Safdar, et al.
Published: (2026) -
Lack of Association Between Donor‐Derived Cell‐Free DNA and Cardiac Allograft Vasculopathy
by: Rami Alharethi, et al.
Published: (2024) -
Association Between Right Ventricular Dysfunction and Cardiac Allograft Vasculopathy in Pediatric Patients Following Heart Transplantation
by: Teruhiko Imamura
Published: (2026) -
Right Ventricular Dysfunction by Echocardiography Is an Early Marker of Evolving Cardiac Allograft Vasculopathy in Children After Heart Transplantation
by: Judith Namuyonga, et al.
Published: (2025) -
Risk Index Predicts Pediatric Heart Allograft Non‐Utilization
by: Jake Lynn, et al.
Published: (2024)